This is the authors' abstract. We don't add key points for this paper.
SF3B1 mutation-driven myelodysplastic syndromes (MDS- SF3B1 ) arise due to somatic mutation in the splicing factor SF3B1 gene. SF3B1 mutations induce RNA mis-splicing and loss of expression of critical genes for erythropoiesis, leading to erythroid dysplasia and ultimately refractory anemia. The development of precision medicine approaches for MDS- SF3B1 is hampered by the complexity of the mis-splicing landscape and its evaluation in disease-accurate model systems. To identify novel RNA mis-splicing events, isogenic SF3B1 K700E and SF3B1 WT iPSC lines from an MDS- SF3B1 patient were differentiated into hematopoietic cells in vitro and subjected to unsupervised splicing event analysis using full-length RNA sequencing data. This revealed SF3B1 K700E -specific mis-splicing of ubiquitin-like modifier activating enzyme 1 ( UBA1 ) transcripts, which encode the essential E1 protein at the apex of the ubiquitination cascade. UBA1 mis-splicing ( UBA1 ms ) preserved UBA1 ms mRNA but not protein expression. Consequently, UBA1 ms diminished the pool of functional UBA1, sensitizing SF3B1 K700E cell lines to the small-molecule UBA1 inhibitor TAK-243. Finally, analysis of CD34 + RNA sequencing data from an MDS patient cohort confirmed unique and ubiquitous UBA1 ms in MDS- SF3B1 patients, without detection in other splicing factor-mutated MDS patients, or in healthy individuals. TAK-243 selectively targeted MDS- SF3B1 primary CD34 + cells and reduced mutant cell number in colony-forming unit studies. In contrast, normal hematopoietic progenitor cells were unaffected. Altogether, we here define UBA1 ms as a novel therapeutic vulnerability in SF3B1 -mutant cells, introducing UBA1 inhibition as a potential avenue for future MDS- SF3B1 treatments.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Thier et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: